P

Paxman AB (publ)
STO:PAX

Watchlist Manager
Paxman AB (publ)
STO:PAX
Watchlist
Price: 51.2 SEK 2.4%
Market Cap: 1.2B SEK

Profitability Summary

Paxman AB (publ)'s profitability score is 52/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

52/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

52/100
Profitability
Score
52/100
Profitability
Score

Margins

Earnings Waterfall
Paxman AB (publ)

Margins Comparison
Paxman AB (publ) Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
SE
Paxman AB (publ)
STO:PAX
1.2B SEK
Loading...
Loading...
Loading...
US
Abbott Laboratories
NYSE:ABT
188.9B USD
Loading...
Loading...
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
188.5B USD
Loading...
Loading...
Loading...
US
Stryker Corp
NYSE:SYK
137.1B USD
Loading...
Loading...
Loading...
US
Boston Scientific Corp
NYSE:BSX
135.3B USD
Loading...
Loading...
Loading...
IE
Medtronic PLC
NYSE:MDT
129.9B USD
Loading...
Loading...
Loading...
US
Becton Dickinson and Co
NYSE:BDX
58.8B USD
Loading...
Loading...
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
49.3B EUR
Loading...
Loading...
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.3B USD
Loading...
Loading...
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
49B USD
Loading...
Loading...
Loading...
US
Resmed Inc
NYSE:RMD
37.3B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Paxman AB (publ) Competitors

Country Company Market Cap ROE ROA ROCE ROIC
SE
Paxman AB (publ)
STO:PAX
1.2B SEK
Loading...
Loading...
Loading...
Loading...
US
Abbott Laboratories
NYSE:ABT
188.9B USD
Loading...
Loading...
Loading...
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
188.5B USD
Loading...
Loading...
Loading...
Loading...
US
Stryker Corp
NYSE:SYK
137.1B USD
Loading...
Loading...
Loading...
Loading...
US
Boston Scientific Corp
NYSE:BSX
135.3B USD
Loading...
Loading...
Loading...
Loading...
IE
Medtronic PLC
NYSE:MDT
129.9B USD
Loading...
Loading...
Loading...
Loading...
US
Becton Dickinson and Co
NYSE:BDX
58.8B USD
Loading...
Loading...
Loading...
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
49.3B EUR
Loading...
Loading...
Loading...
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.3B USD
Loading...
Loading...
Loading...
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
49B USD
Loading...
Loading...
Loading...
Loading...
US
Resmed Inc
NYSE:RMD
37.3B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Paxman AB (publ)

Last Value
3-Years Average
FCF Margin
Conversion Rate